Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genvor is a biotechnology company that utilizes its proprietary AI-accelerated BioCypher platform to design and develop high-performance peptide solutions for both sustainable agriculture and human health. The company's technology addresses critical agricultural challenges such as crop pathogens and nutrient optimization while expanding into the consumer wellness market with products for muscle recovery, performance, and anti-aging. Genvor operates a dual-market model, employing a licensing-first approach for its agricultural traits and a direct-to-consumer strategy for its human health innovations. With a robust library of millions of designed peptides and strategic partnerships with organizations like the USDA, Genvor is positioned to deliver science-backed biological solutions across multiple global industries. The company's lead agricultural programs include traits for aflatoxin resistance in corn and disease protection in citrus, both of which have advanced to field trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genvor.